Article Listing - Biogen and Biovitrum update hemophilia agreement; MorphoSys and Galapagos expand accord

FURTHER WELLCOME SHARE SELL-OFF

9 March 1992

Six years after the first share floatation in UK drugmaker Wellcome, the Wellcome Trust has revealed that a further tranche...

TURNOVER UP 39% AT LUNDBECK UK

9 March 1992

In the UK, pharmaceutical concern Lundbeck says it is set for a healthy future following its latest annual results. For...

INNOTHERA SEEKING DEVELOPMENT CASH

9 March 1992

The French drug manufacturer, Innothera, which specializes in products for women's diseases, says it is ready to open its capital...

WARNING LETTER TO MILES ON NIMOTOP

9 March 1992

Promotion of the neurone-specific calcium channel blocker Nimotop (nimodipine) in the USA by Miles Laboratories for the unapproved indication of...

BULLETIN REVIEWS NEW TOPICAL PRODUCTS

9 March 1992

Leo Laboratories' Dovonex (calcipotriol) represents an interesting and useful addition to the menu of treatments available for chronic plaque psoriasis,...

MEDEVA'S NEW CORACTEN FORM

9 March 1992

Medeva plc and its subsidiary Evans Medical have launched in the UK a new product in the Coracten (nifedipine) range....

UK DTP VACCINATION SCHEDULE

9 March 1992

New findings released by a team of UK clinicians, under the direction of Robert Booy of the Radcliffe Hospital, Oxford,...

US APPROVAL FOR CARDENE SR

9 March 1992

Syntex Corp has received approval from the US Food and Drug Administration to market its Cardene SR, a slow-release formulation...

MMD'S 5HT3 RECEPTOR ANTAGONIST

9 March 1992

The pharmacokinetic properties of a new anti-emetic 5-HT3 receptor antagonist from Marion Merrell Dow, MDL 73,147EF, will be described at...

RISING HEALTH CARE COSTS IN SPAIN

17 February 1992

Family expenditure in Spain on medication has progressively fallen in recent years, and at the same time, the costs of...

Showing 94741-94750 of 95337 articles